Do H. pylori and intestinal protozoa increase mucosal secretory IgA?

The interaction between the mucosal immune system and chronic gastrointestinal colonization involves complex feedback loops. Evidence supports the claim that Helicobacter pylori and certain intestinal protozoa drive mucosal immune activation, resulting in elevated levels of secretory IgA (sIgA).

Clinical and effectiveness evidence

Research consistently demonstrates that H. pylori and intestinal protozoa significantly impact mucosal antibody production.

• H. pylori dynamics: Infection with H. pylori is a potent driver of gastric mucosal immune activation. Studies show a marked accumulation of IgA-secreting plasma cells in the gastric mucosa. Consequently, significant elevations of total sIgA are observed in gastric secretions and feces (p < 0.05 in several clinical cohorts) of infected individuals.
• Protozoan interactions: Protozoa like Blastocystis and Tritrichomonas interact with gut-associated lymphoid tissue (GALT), specifically Peyer's patches. This interaction stimulates B-cell class switching to IgA. While evidence for specific commensal amoebas (e.g., Endolimax nana) is more varied—with some studies suggesting a more tolerogenic or immunosuppressive role—the general mechanism of protozoan-induced sIgA elevation is well-documented as a means of limiting epithelial adhesion.

Mechanistic explanations

The elevation of sIgA is a direct result of sustained antigenic stimulation and specific cytokine signaling pathways.

• Th17 pathway activation: H. pylori utilizes a type IV secretion system to induce Th17 cell generation. These cells produce IL-17, which is a critical regulator for the expression of the polymeric immunoglobulin receptor (pIgR). This receptor is responsible for transporting IgA across the mucosal epithelium and into the lumen.
• Pathogen persistence and "coating": Interestingly, increased sIgA does not always result in pathogen clearance. H. pylori often becomes coated in sIgA, which helps it evade complement-mediated killing and facilitates persistent colonization.
• Chronic antigen reservoirs: Persistent reservoirs of pathogens provide a continuous source of antigens. This chronic exposure drives the differentiation of plasma cells in the lamina propria through both T-cell dependent and independent pathways, maintaining high levels of sIgA to preserve barrier homeostasis.

Bottom line

Ongoing exposure to H. pylori and intestinal protozoa triggers mucosal immune activation via Th17/IL-17 signaling and GALT stimulation. This leads to increased production and secretion of sIgA, which serves both as a host defense mechanism and, in some cases, a means for the pathogen to persist within the mucosal niche.